tiprankstipranks
Trending News
More News >
Nuvectis Pharma (NVCT)
NASDAQ:NVCT
US Market

Nuvectis Pharma (NVCT) Income Statement

Compare
118 Followers

Nuvectis Pharma Income Statement

Last quarter (Q4 2025), Nuvectis Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Nuvectis Pharma's net income was $-7.31M. See Nuvectis Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 27.57M$ 19.85M$ 22.90M$ 19.23M$ 12.89M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
EBITDA
$ -27.57M$ -19.00M$ -22.90M$ -19.23M$ -12.89M
Operating Income
$ -27.57M$ -19.85M$ -22.90M$ -19.23M$ -12.89M
Other Income/Expenses
$ 1.13M$ 847.00K$ 637.00K$ 149.00K$ 4.00K
Pretax Income
$ -26.44M$ -19.00M$ -22.26M$ -19.09M$ -12.89M
Net Income
$ -26.44M$ -19.00M$ -22.26M$ -19.09M$ -12.89M
Per Share Metrics
Basic EPS
$ -1.32$ -1.11$ -1.43$ -1.51$ -1.09
Diluted EPS
$ -1.32$ -1.11$ -1.43$ -1.51$ -1.09
Weighted Average Shares Outstanding
21.81M 17.11M 15.56M 12.66M 12.72M
Weighted Average Shares Outstanding (Diluted)
21.81M 17.11M 15.56M 12.66M 12.72M
Currency in USD

Nuvectis Pharma Earnings and Revenue History